Showing results (151-160 of 182) with videos related to
Sort By:
Pageof 19
European Journal of Nuclear Medicine and Molecular Imaging|January 26, 2021
A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticalsTeja Muralidhar Kalidindi, Sang-Gyu Lee, Katerina Jou, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 26, 2026
Delta-like Ligand 3-Directed <sup>225</sup>Ac Radioimmunotherapy in Neuroendocrine Lung and Prostate Cancer ModelsTran T Hoang, David Bauer, Aidan Ingham, et al.Neuroendocrinology|April 18, 2019
Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/NeoplasmsSomer Matar, Anna Malczewska, Kjell Oberg, et al.Neuroendocrinology|May 24, 2022
Treatment Response and Clinical Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors to Lutetium-177-DOTATATENitya Raj, Kelley Coffman, Tiffany Le, et al.Annals of Surgical Oncology|May 19, 2021
Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest)Irvin M Modlin, Mark Kidd, Kjell Oberg, et al.Bioconjugate Chemistry|April 5, 2021
Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy ApplicationsMegan M Dacek, Darren R Veach, Sarah M Cheal, et al.Neuroendocrinology|January 18, 2019
NETest Liquid Biopsy Is Diagnostic of Lung Neuroendocrine Tumors and Identifies Progressive DiseaseAnna Malczewska, Kjell Oberg, Lisa Bodei, et al.Physics in Medicine and Biology|November 10, 2025
The UF/MSK adult mesh-based computational human phantom library: applications to organ dosimetry in computed tomographyRobert J Dawson, Jared M Baggett, Laura E Dinwiddie, et al.Journal of Neuroendocrinology|October 20, 2021
ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumoursRodney J Hicks, Clarisse Dromain, Wouter W de Herder, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2025
Dosimetry of [<sup>177</sup>Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 TrialLisa Bodei, Marta Cremonesi, Mahila Ferrari, et al.Pageof 19